Through differential activation of ABC Transporters, Limerick has created a breakthrough platform for selective removal of harmful drugs and endogenous substances from unintended tissues and organs
At Limerick BioPharma, we seek to activate cell surface transporters in order to protect cells from toxic drugs and unwanted endogenous substances. Our novel library of small molecules is optimized to selectively remove harmful drugs and cellular byproducts from unintended tissues. This groundbreaking platform technology provides therapeutic opportunities for various drug classes and disease states.
